Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions

Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions

Acute myeloid leukemia (AML) is an aggressive malignant disease with a high relapse rate due to the persistence of chemoresistant cells. To some extent, these residual cells can be traced by sensitive flow cytometry and molecular methods resulting in the establishment of measurable residual disease...

Full description

Bibliographic Details
Main Authors: Jennifer Moritz, Antonia Schwab, Andreas Reinisch, Armin Zebisch, Heinz Sill, Albert Wölfler
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Biomedicines
Subjects:
acute myeloid leukemia
measurable residual disease
risk-stratification
MRD detection methods
postremission decision
Online Access:https://www.mdpi.com/2227-9059/12/3/599

Internet

https://www.mdpi.com/2227-9059/12/3/599

Similar Items